Cite
Identification of a therapeutic interfering particle—A single-dose SARS-CoV-2 antiviral intervention with a high barrier to resistance.
MLA
Chaturvedi, Sonali, et al. “Identification of a Therapeutic Interfering Particle—A Single-Dose SARS-CoV-2 Antiviral Intervention with a High Barrier to Resistance.” Cell, vol. 184, no. 25, Dec. 2021, p. 6022. EBSCOhost, https://doi.org/10.1016/j.cell.2021.11.004.
APA
Chaturvedi, S., Vasen, G., Pablo, M., Chen, X., Beutler, N., Kumar, A., Tanner, E., Illouz, S., Rahgoshay, D., Burnett, J., Holguin, L., Chen, P.-Y., Ndjamen, B., Ott, M., Rodick, R., Rogers, T., Smith, D. M., & Weinberger, L. S. (2021). Identification of a therapeutic interfering particle—A single-dose SARS-CoV-2 antiviral intervention with a high barrier to resistance. Cell, 184(25), 6022. https://doi.org/10.1016/j.cell.2021.11.004
Chicago
Chaturvedi, Sonali, Gustavo Vasen, Michael Pablo, Xinyue Chen, Nathan Beutler, Arjun Kumar, Elizabeth Tanner, et al. 2021. “Identification of a Therapeutic Interfering Particle—A Single-Dose SARS-CoV-2 Antiviral Intervention with a High Barrier to Resistance.” Cell 184 (25): 6022. doi:10.1016/j.cell.2021.11.004.